NEWSROOM Blog

Biodesix Biopharma Communication in Response to COVID-19

March 16, 2020

Biodesix is monitoring the COVID-19 news, including all recommendations from our local, state, and federal health agencies. The world is grappling with an issue of enormous scale and human impact, and our hearts go out to all who have been affected by the outbreak of COVID-19.

Infographic: What is a Lung Nodule?

November 13, 2020

For Lung Cancer Awareness Month Biodesix created an infographic to help explain the problem of lung nodules and how physicians take care of them.

Pulmonologists Responding to the COVID-19 Pandemic

April 7, 2020

We are committed to supporting patients and health care providers during the COVID-19 pandemic. Biodesix will continue lab operations without disruption to provide diagnostic testing for patients with, or at risk for lung cancer.

REAL WORLD DATA: Performance of Blood-Based Proteomic Profiling in Immunotherapy-Treated Advanced Stage NSCLC Patients

March 20, 2020

The VeriStrat® proteomic test was designed using mass spectrometry combined with our proprietary artificial intelligence platform. View case study!

The Nodify XL2™ blood test helps direct next steps in lung nodule management [Video]

January 15, 2020

Physicians discuss how the Nodify XL2 test is helping identify benign pulmonary nodules and relieve patient anxiety. Watch the video now!

CASE STUDY: Longitudinal Monitoring for the Emergence of EGFR C797S resistance mutations in NSCLC using blood-based Droplet Digital PCR

March 20, 2020

Case study on Longitudinal Monitoring for the Emergence of EGFR C797S resistance mutations in NSCLC using blood-based Droplet Digital PCR.